Smoking Cessation for Patients With Cancer: State of the Evidence

Presented by:
James M. Davis
Search for other papers by James M. Davis in
Current site
Google Scholar
PubMed
Close
 MD
,
Donna Edmondson
Search for other papers by Donna Edmondson in
Current site
Google Scholar
PubMed
Close
 CRNP, AOCNP, NCTTP
, and
Mary E. Reid
Search for other papers by Mary E. Reid in
Current site
Google Scholar
PubMed
Close
 MSPH, PhD
Moderated by:
Laura Jean Bierut
Search for other papers by Laura Jean Bierut in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access

Although it is generally well-known that smoking poses numerous risks to physical health and well-being, it carries additional risks for patients with cancer. Therefore, smoking cessation is of particular concern among this patient population. At the NCCN 2025 Annual Conference, a panel convened to discuss the current evidence surrounding smoking-associated risks for patients with cancer, the benefits of smoking cessation specific to them, and evidence-based approaches to improve rates of smoking cessation.

Disclosures: Dr. Davis has disclosed receiving consulting fees from Currax Pharmaceuticals LLC; receiving grant/research support from Delfi Diagnostics, Inc.; and owning equity interest/stock options in Predictably Human. Dr. Reid has disclosed serving as a scientific advisor for Johnson & Johnson. The remaining presenters have disclosed no relevant financial relationships.

Correspondence: James M. Davis, MD, Duke Cancer Institute, 4220 North Roxboro Street, Durham, NC 27704. Email: james.m.davis@duke.edu;
Donna Edmondson, CRNP, AOCNP, NCTTP, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111. Email: donna.edmondson@fccc.edu;
Mary E. Reid, MSPH, PhD, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Department of Medicine, Buffalo, NY 14263. Email: mary.reid@roswellpark.org; and
Laura Jean Bierut, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, 660 South Euclid Avenue, Box 8134, St. Louis, MO 63110. Email: laura@wustl.edu
  • Collapse
  • Expand
  • 1.

    Lindson N, Theodoulou A, Ordóñez-Mena J, et al. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. Cochrane Database Syst Rev 2023;9:CD015226.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2016;3:CD008286.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Shields PG, Bierut LJ, Arenberg D, et al. NCCN Clinical Practice Guidelines in Oncology: Smoking Cessation. Version 2.2024. Accessed March 31, 2025. To view the most recent version, visit https://www.nccn.org

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 252 252 252
PDF Downloads 98 98 98
EPUB Downloads 0 0 0